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Abstract
Background: Hereditary spherocytosis is autosomal dominant inherited extravascular hemolytic disorder and is the
commonest cause of inherited hemolysis in northern Europe and the United States. The classical clinical features of
hereditary spherocytosis are anemia, jaundice, and splenomegaly. However, all of these classical features are not
always revealed in the case of mild hemolysis or when hemolysis is well compensated. Patients with hereditary
spherocytosis may remain undiagnosed for years if their hemolysis is mild.
Case presentation: A 42-year-old Asian woman presented to our clinic with a sudden onset of high fever
with shaking chills and jaundice, suggesting septicemia; however, following detailed investigation, the patient
was diagnosed with pyelonephritis and accelerated hemolysis of hereditary spherocytosis due to infection.
Conclusions: It is important to note that transient anemia or jaundice can sometimes be the only initial
presenting symptoms in cases of undiagnosed latent hereditary spherocytosis. This case also highlights the
fact that physicians should consider concomitant hemolytic disease in patients in whom jaundice and infections that
rarely cause jaundice coexist.
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Background
Hereditary spherocytosis (HS) is an autosomal dominant
inherited extravascular hemolytic disorder and is the
commonest cause of inherited hemolysis in northern
Europe and the United States [1]. The classical clinical
features of HS are anemia, jaundice, and splenomegaly
[1, 2]. However, all of these classical features are not
always revealed in the case of mild hemolysis or when
hemolysis is well compensated, because the bone marrow
is able to increase red cell output. Patients with HS may
remain undiagnosed for years if their hemolysis is mild.
Case presentation
A 42-year-old Asian woman presented to our clinic with
a sudden onset of high fever with shaking chills and
jaundice. The patient was in her usual good health until
5 days earlier, when she started to have chills and fever.
Jaundice had become manifest 2 days earlier. She had a
past medical history of cholangitis due to gallbladder
stones, for which she had undergone laparoscopic chole-
cystectomy 3 months before. She had no family history
of hemolytic diseases. She was alert; her temperature
was 39.3 °C, her blood pressure was 122/61 mmHg, and
her pulse rate was regular at 119 per minute. Her respir-
ation rate was within normal range. Her physical exam-
ination revealed icteric skin and sclera, but she had no
abdominal or costovertebral angle tenderness. There
were no other specific findings in her physical examin-
ation. A routine hematological examination showed nor-
mocytic normochromic anemia with hemoglobin 9.0 g/dl.
The patient’s reticulocyte count was elevated at 25.0%,
her white blood cell count was 10,580/μl, and her blood
platelet count was 125,000/μl. The patient’s liver function
test values were elevated: total bilirubin 10.9 mg/dl with
direct bilirubin of 6.0 mg/dl, aspartate aminotransferase
49 IU/L, alanine aminotransferase 65 IU/L, alkaline phos-
phatase 441 IU/L, lactate dehydrogenase 550 IU/L, and
γ-glutamyl transferase 301 IU/L. Other blood chemistry
findings were all within normal limits. Coagulation test
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results were within normal limits, with a prothrombin
time 89% of normal and an activated partial thromboplas-
tin time of 26.0 seconds. A blood culture was positive
for Escherichia coli.
The initial clinical impression was septicemia due to
acute obstructive suppurative cholangitis caused by a com-
bination of high fever, jaundice, and elevated liver function
values accompanied with hyperbilirubinemia in which dir-
ect bilirubin was dominant. The patient immediately under-
went abdominal contrast-enhanced computed tomography,
which revealed splenomegaly and a distended left kidney.
However, no signs of biliary tract obstruction were present.
At this point, urinalysis was performed to evaluate the pos-
sibility of pyelonephritis. The urinalysis results were 3+ test
for leukocytes, 2+ for nitrate, 3+ for hemoglobin, 2+ for
bilirubin, and 3+ for urobilinogen. The patient’s urinary
sediment was loaded with white cells and bacteria and con-
tained five to nine erythrocytes per high-power field. Her
urine culture was positive for E. coli. The urinalysis findings
suggested the diagnosis of septicemia due to pyelonephritis;
however, the cause of the patient’s hyperbilirubinemia was
unclear. Other infections accompanied with hyperbilirubi-
nemia, such as infectious mononucleosis, malaria, and Weil
syndrome (leptospirosis), were unlikely in light of negative
findings of the microbiological examination and peripheral
blood smear.
The patient was supposed to have concurrent hemolysis
because of anemia, hyperbilirubinemia, and urobilinoge-
nuria. To substantiate the diagnosis of hemolysis, the fol-
lowing laboratory examinations were performed. The
patient’s haptoglobin level was 8 mg/dl (normal range
19–200 mg/dl), and the results of direct and indirect
Coombs tests were negative. A peripheral blood smear
showed normal red blood cells with spherocytosis (Fig. 1).
On the basis of the peripheral blood smear findings,
splenomegaly and the patient’s past history of cholelithiasis,
HS was strongly suspected. An osmotic fragility test was
performed, which showed increased fragility. Thus, the
diagnosis of undiagnosed HS was confirmed, and the
patient’s clinical condition was diagnosed as pyelonephritis
and accelerated hemolysis of HS due to infection. Her
family members were queried whether they had HS,
according to the patient’s wish, and her father was diag-
nosed with HS on the basis of a peripheral blood smear
and an osmotic fragility test. The patient was treated with
meropenem as an intravenous antibiotic for 14 days and
with oral cephalexin for 30 days. She recovered well and
was discharged 18 days after admission. Fourteen days
after discharge, her laboratory values normalized. It was
decided that if she experienced chronic severe hemolysis
and anemia, a splenectomy would be scheduled.
Discussion
To our knowledge, this is the first description of a case
of significant jaundice due to excessive hemolysis induced
by pyelonephritis based on undiagnosed HS. The patient
presented with hemolysis and jaundice in the presence of
pyelonephritis. Our initial clinical impression was septi-
cemia due to acute obstructive suppurative cholangitis
caused by a combination of high fever, jaundice, and
elevated liver function values accompanied with hyperbi-
lirubinemia. If HS had not been recognized, unnecessary
and invasive procedures such as endoscopic retrograde
cholangiopancreatography or emergency operation might
have been done.
To substantiate a diagnosis of HS, several laboratory
examinations were performed. Autoimmune hemolytic
anemia can also cause hemolysis; however, it was excluded
because the results of direct and indirect Coombs tests
were negative. Thrombotic thrombocytopenic purpura
(TTP) and hemolytic uremic syndrome (HUS) should be
considered in the differential diagnosis when encountering
the combination of hemolysis, slight thrombocytopenia,
and jaundice in the presence of pyelonephritis. However,
the absence of neurological symptoms, kidney failure, and
abnormal red blood cells such as burr cells or helmet cells
excluded TTP and HUS in our patient. Ultimately, on the
basis of the patient’s spherocytosis, splenomegaly, and past
history of cholelithiasis, HS was strongly suspected.
HS is an autosomal dominant inherited extravascular
hemolytic disorder and is the commonest cause of inher-
ited hemolysis in northern Europe and the United States
[1]. The pathological cause of HS is deficiency or dysfunc-
tion of proteins of the red cell membrane. The molecular
defect may involve the genes encoding spectrin, ankyrin,
band 3, or protein 4.2. Deficiency or dysfunction of any of
these proteins, all of which are involved in the attachment
of the cytoskeleton to the membrane integral domain,
results in a loss of surface area and leads to spheroidal,
osmotically fragile red blood cells that are selectively
Fig. 1 The patient’s peripheral blood smear on admission. The black
arrow shows a spherocyte. The white arrow shows a normal red
blood cell
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trapped in the spleen and destroyed [1]. HS itself is not a
life-threatening disease; however, two comorbidities can
induce a serious medical condition in patients with HS.
The most alarming comorbid disease in patients with
HS is parvovirus B19 infection. In patients with HS,
parvovirus B19 infection leads to severe red cell aplasia
and a sudden, profound fall in hemoglobin level, and
transfusion is sometimes required [1]. Patients with HS
who have not had parvovirus infection should be warned
of possible future infection.
The second is cholelithiasis, which is prone to coexist
with HS. Hemolysis is associated with increased red cell
turnover and an increased pigment load for the liver,
and this may result in the development of gallstones [1].
Gallbladder stones can cause cholecystitis, cholangitis,
or pancreatitis, and these diseases sometimes require
operation or therapeutic endoscopy.
The classical clinical features of HS are anemia, jaundice,
and splenomegaly [1, 2]. However, all of these classical
features are not always revealed in the case of mild
hemolysis or when hemolysis is well compensated, because
the bone marrow is able to increase red cell output [1, 2].
Actually, patients with HS may remain undiagnosed for
years if their hemolysis is mild.
An increase in hemolysis, which presents as transient
anemia or jaundice, is sometimes produced by stress or
other infections [1, 2]. Activation of the reticuloendothe-
lial system during infection is thought to bring about
this increase [3]. The transient anemia or jaundice can
be the only initial presentation for patients with undiag-
nosed latent HS. If HS is clinically suspected, the periph-
eral blood smear is the simplest but most important
examination [2]. Routine hematological and blood chem-
ical tests such as hemoglobin, reticulocyte, bilirubin, and
direct and indirect Coombs tests are also helpful [2].
An osmotic fragility test is sometimes performed to make
a definitive diagnosis; however, it is time-consuming and
labor-intensive, and it is not essential for making the diag-
nosis if there are obvious spherocytes [1, 2]. The process
of diagnosis is not difficult if physicians do not miss the
clinical signs of HS and suspect it. In other words, to
reveal undiagnosed HS, awareness of HS is most impor-
tant in cases of jaundice and/or anemia accompanied with
infections.
Conclusions
Especially when jaundice is present with infections that
rarely cause jaundice by themselves, physicians should con-
sider the concomitance of hemolytic disease. In addition,
the existence of splenomegaly and a past history of chole-
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